Comparison of surface MHC class I expression levels on each cell line used for immunization shows that MHC class I levels are comparable between MT/ShcA+/+ and MT/Shc2F/2F breast cancer cells, even though only the latter is exquisitely sensitive to tumour vaccination. This evidence concerns the gene SHC1 and breast cancer.